Skip to main content
. 2018 Jul 30;45(13):2300–2306. doi: 10.1007/s00259-018-4099-8

Table 3.

Treatment decision before and after 89Zr-trastuzumab PET

Treatment planned before 89Zr-trastuzumab PET Treatment given after 89Zr-trastuzumab PET
Anti-HER2 (± chemo) No anti-HER2 (other systemic treatment) No systemic treatment
• Anti-HER2 (± chemo) 5 2 0
• No anti-HER2 (other systemic treatment) 2 4 0
• No systemic treatment 1 0 3
• Unsure on systemic treatment choice/dependent on additional test 2 1 0